INVO Fertility (IVF) Shareholder's Equity Growth (3y) (2013 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | INVO Fertility | 5.12 Mn | 4.76 Mn | 629,345.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 65.63% |
| Jun 30, 2025 | -7.79% |
| Mar 31, 2025 | -15.81% |
| Dec 31, 2024 | 20.36% |
| Sep 30, 2024 | -26.20% |
| Jun 30, 2024 | -32.11% |
| Mar 31, 2024 | -87.80% |
| Dec 31, 2023 | -46.23% |
| Sep 30, 2023 | 27.97% |
| Jun 30, 2023 | 22.03% |
| Mar 31, 2023 | 26.41% |
| Dec 31, 2022 | 35.91% |
| Sep 30, 2022 | 32.80% |
| Jun 30, 2022 | 45.22% |
| Mar 31, 2022 | 56.07% |
| Dec 31, 2021 | 67.31% |
| Sep 30, 2021 | 36.30% |
| Jun 30, 2021 | 45.09% |
| Mar 31, 2021 | 46.44% |
| Dec 31, 2020 | 46.60% |
| Sep 30, 2020 | 7.18% |
| Jun 30, 2020 | 9.19% |
| Mar 31, 2020 | 2.02% |
| Dec 31, 2019 | 7.01% |
| Sep 30, 2019 | 4.67% |
| Jun 30, 2019 | 8.55% |
| Mar 31, 2019 | 7.64% |
| Dec 31, 2018 | 10.16% |
| Sep 30, 2018 | -2.57% |
| Jun 30, 2018 | -0.76% |
| Mar 31, 2018 | -3.10% |
| Dec 31, 2017 | -4.62% |
| Sep 30, 2017 | -4.82% |
| Jun 30, 2017 | -5.26% |
| Mar 31, 2017 | -6.24% |
| Dec 31, 2016 | -6.57% |
| Sep 30, 2016 | -4.14% |
| Jun 30, 2016 | -4.17% |
| Mar 31, 2016 | -3.04% |
| Dec 31, 2015 | -3.66% |
| Sep 30, 2015 | -6.99% |
| Jun 30, 2015 | -8.94% |
| Mar 31, 2015 | -13.63% |
| Dec 31, 2014 | -14.22% |
| Sep 30, 2014 | -13.08% |
| Jun 30, 2014 | -12.35% |
| Dec 31, 2013 | -15.41% |